The official blog of the Lung Institute.

Is Black Lung Treatable? 

Lung Graphic

There is no cure for black lung disease, so treatment usually focuses on relieving symptoms and improving quality of life. Black lung, or coal worker’s pneumoconiosis (CWP), is an occupational lung disease that most commonly affects miners who have inhaled coal dust over an extended period of time.

A black lung treatment regimen will vary based on whether a person has a simple or complicated form of CWP and what specific symptoms are being experienced. Generally speaking, medications and supplemental oxygen may be used to improve breathing and control co-existing symptoms from related conditions, such as chronic obstructive pulmonary disease (COPD). Lung transplantation may be recommended for patients with very severe cases of black lung.

Autologous stem cell therapy is an alternative black lung treatment that is showing encouraging results in some patients. This treatment involves using the patient’s own stem cells to promote the body’s natural healing processes, which may in turn help reduce lung inflammation and ease unpleasant symptoms like coughing and shortness of breath. Because stem cells are found naturally in the body and are not a drug, most patients don’t experience any negative side effects.

The Lung Institute offers the latest breakthroughs in autologous stem cell therapy to adults with black lung disease and other chronic lung conditions. As the only stem cell center in the world to focus exclusively on lung disease, the Lung Institute can be your first choice for stem cell-based black lung treatment. Consider contacting our friendly medical team today at (800) 729-3065 if traditional treatment approaches are not providing the symptom relief you desire. We will be happy to answer any questions you may have and determine if you are a potential candidate for stem cell therapy.

Your Comment

Your email address will not be published.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.